Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 116,204,808
  • Shares Outstanding, K 257,529
  • Annual Sales, $ 9,869 M
  • Annual Income, $ 3,620 M
  • EBIT $ -270 M
  • EBITDA $ -89 M
  • 60-Month Beta 0.39
  • Price/Sales 11.69
  • Price/Cash Flow 30.57
  • Price/Book 7.40

Options Overview Details

View History
  • Implied Volatility 46.40% ( +0.88%)
  • Historical Volatility 31.88%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 46.40% on 11/21/24
  • IV Low 17.64% on 05/16/24
  • Put/Call Vol Ratio 0.91
  • Today's Volume 1,167
  • Volume Avg (30-Day) 2,632
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 52,120
  • Open Int (30-Day) 43,456

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 33 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 3.51
  • Number of Estimates 12
  • High Estimate 4.43
  • Low Estimate 2.98
  • Prior Year 3.57
  • Growth Rate Est. (year over year) -1.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
445.13 +1.20%
on 11/21/24
519.88 -13.35%
on 11/08/24
-27.60 (-5.77%)
since 10/21/24
3-Month
445.13 +1.20%
on 11/21/24
519.88 -13.35%
on 11/08/24
-35.62 (-7.33%)
since 08/21/24
52-Week
346.29 +30.09%
on 11/28/23
519.88 -13.35%
on 11/08/24
+95.71 (+26.98%)
since 11/21/23

Most Recent Stories

More News
MCK Stock Down Despite Latest Partnership to Boost SCD Treatment

McKesson Corporation’s MCK dedicated business focused on supporting the commercialization of cell and gene therapies, InspiroGene, has been selected by Vertex Pharmaceuticals Incorporated VRTX to expand...

MCK : 628.90 (+1.25%)
COR : 245.05 (+0.76%)
VRTX : 450.18 (-0.23%)
CAH : 122.60 (+1.88%)
3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Many investors have a type of acrophobia (the fear of heights). It's not that they're worried about standing at the top of a ladder. Instead, their concern is focused on putting money in stocks when the...

NVO : 103.12 (-2.04%)
LLY : 750.02 (-0.45%)
VRTX : 450.18 (-0.23%)
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More

Biotechs often need several years to realize their visions, even after they have a drug approved for the first time. There's typically plenty of upside in store for enterprising and patient investors.

CRSP : 46.29 (-2.05%)
IOVA : 8.24 (+1.23%)
VRTX : 450.18 (-0.23%)
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity

Regulators are reviewing what could become a multi-billion-dollar drug.

VRTX : 450.18 (-0.23%)
2 Biotech Stocks You Can Buy Hand Over Fist This Month

Both stocks have made significant breakthroughs.

VRTX : 450.18 (-0.23%)
MRNA : 37.73 (+2.14%)
1 Penny Stock to Grab Now for 183% Upside Potential

This biotech penny stock could more than triple, based on consensus forecasts.

VRTX : 450.18 (-0.23%)
EDIT : 2.38 (-1.24%)
BMY : 58.34 (+0.79%)
Stocks Finish Higher as Chip Makers Rally

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +1.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.32%. Stocks rallied on...

APO : 165.19 (+1.41%)
DD : 82.98 (+1.38%)
AMAT : 176.80 (+3.94%)
AVGO : 165.16 (+1.17%)
HSIC : 72.87 (-1.17%)
WYNN : 91.04 (-0.20%)
ADM : 53.31 (+0.55%)
$IUXX : 20,757.08 (+0.44%)
ZNZ24 : 109-175 (-0.13%)
GFS : 42.50 (+2.02%)
LPX : 114.37 (+2.68%)
LRCX : 72.98 (+4.18%)
Stocks Rally on Chip Stock Strength

The S&P 500 Index ($SPX ) (SPY ) today is up +0.95%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.08%. Stocks are climbing today, supported...

APO : 165.19 (+1.41%)
DD : 82.98 (+1.38%)
AMAT : 176.80 (+3.94%)
AVGO : 165.16 (+1.17%)
HSIC : 72.87 (-1.17%)
LSCC : 52.46 (+3.37%)
WYNN : 91.04 (-0.20%)
ADM : 53.31 (+0.55%)
$IUXX : 20,757.08 (+0.44%)
ZNZ24 : 109-175 (-0.13%)
GFS : 42.50 (+2.02%)
LPX : 114.37 (+2.68%)
5 Top Stocks to Buy in November

From blue chip dividend stocks to industry-leading growth stocks, there are plenty of bargains in today's market if you know where to look.

MSFT : 412.69 (-0.48%)
ROKU : 68.85 (+0.20%)
KO : 63.57 (+0.92%)
$SPX : 5,953.70 (+0.62%)
VRTX : 450.18 (-0.23%)
BYDDY : 67.7800 (-0.12%)
My 2 Favorite Growth Stocks to Buy Hand Over Fist in November

The sky's the limit for these stocks.

VRTX : 450.18 (-0.23%)
AMZN : 197.35 (-2.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 459.91
2nd Resistance Point 455.84
1st Resistance Point 453.53
Last Price 450.18
1st Support Level 447.16
2nd Support Level 443.08
3rd Support Level 440.78

See More

52-Week High 519.88
Fibonacci 61.8% 453.57
Last Price 450.18
Fibonacci 50% 433.09
Fibonacci 38.2% 412.60
52-Week Low 346.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar